A dose response evaluation of delta-1-testololactone in advanced breast cancer.
D000328:Adult; D000367:Age Factors; D000368:Aged; D001943:Breast Neoplasms / Q000188:drug therapy* / Q000628:therapy; D002369:Castration; D004305:Dose-Response Relationship, Drug; D005069:Evaluation Studies as Topic; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D008875:Middle Aged; D009362:Neoplasm Metastasis; D010053:Ovary; D010166:Palliative Care; D011446:Prospective Studies; D012075:Remission, Spontaneous; D013738:Testolactone / Q000008:administration & dosage* / Q000009:adverse effects / Q000627:therapeutic use
D013738:Testolactone